These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9453943)

  • 21. Omeprazole and ultrastructural modifications occurring in reflux esophagitis.
    Calabrese C; Areni A; Miglioli M; DiFebo G
    Gastroenterology; 2002 Mar; 122(3):837. PubMed ID: 11878295
    [No Abstract]   [Full Text] [Related]  

  • 22. Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis.
    Chen CY; Lu CL; Luo JC; Chang FY; Lee SD; Lai YL
    World J Gastroenterol; 2005 May; 11(20):3112-7. PubMed ID: 15918199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 24. [Safety of proton pump inhibitors for long-term application].
    Kuipers E
    Eksp Klin Gastroenterol; 2006; (4):48-52. PubMed ID: 17269424
    [No Abstract]   [Full Text] [Related]  

  • 25. [The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].
    Bayerdörffer E
    Z Gastroenterol; 2000 Jan; 38(1):131-2. PubMed ID: 10689750
    [No Abstract]   [Full Text] [Related]  

  • 26. [What is the effect of omeprazole in acute peptic ulcer hemorrhage?].
    Kohler B
    Leber Magen Darm; 1995 Jul; 25(4):153. PubMed ID: 7564864
    [No Abstract]   [Full Text] [Related]  

  • 27. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reflux disease. Don't annoy your patients with ineffective general measures!].
    Stiefelhagen P
    MMW Fortschr Med; 2002 Mar; 144(10):18. PubMed ID: 11928258
    [No Abstract]   [Full Text] [Related]  

  • 29. Omeprazole and the development of acute hepatitis.
    Koury SI; Stone CK; La Charité DD
    Eur J Emerg Med; 1998 Dec; 5(4):467-9. PubMed ID: 9919455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fundic metaplasia with parietal cell hyperplasia of the antrum: a lesion possibly associated with long term use of omeprazole.
    Declich P; Ambrosiani L; Prada A; Bortoli A; Bellone S; Tavani E; Gozzini C
    Am J Gastroenterol; 1999 Aug; 94(8):2317-9. PubMed ID: 10445579
    [No Abstract]   [Full Text] [Related]  

  • 31. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P; Fuchs W; Peifer-Weiss A; Simon B
    Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous infusion or repeated intravenous bolus injection of high-dose omeprazole in patients at high risk of rebleeding from peptic ulcers?
    Netzer P; Inauen W
    Am J Gastroenterol; 2006 Dec; 101(12):2888-9; author reply 2889. PubMed ID: 17227532
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug therapy of ulcer and reflux esophagitis. Recommendations from a group of experts].
    Lakartidningen; 1993 Jul; 90(28-29):2530-2. PubMed ID: 8326797
    [No Abstract]   [Full Text] [Related]  

  • 35. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcers after successful endoscopic therapy.
    Eloubeidi M; Rockey DC
    Gastrointest Endosc; 1999 Aug; 50(2):292-3. PubMed ID: 10523140
    [No Abstract]   [Full Text] [Related]  

  • 36. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
    Simon-Rudler M; Massard J; Bernard-Chabert B; DI Martino V; Ratziu V; Poynard T; Thabut D
    Aliment Pharmacol Ther; 2007 Apr; 25(8):949-54. PubMed ID: 17402999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux.
    Calabrese C; Fabbri A; Bortolotti M; Cenacchi G; Carlo S; Zahlane D; Miglioli M; Di Febo G
    World J Gastroenterol; 2005 Mar; 11(12):1876-80. PubMed ID: 15793885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a need for strong gastric acid inhibition in clinical practice?
    Lamers CB
    Digestion; 1989; 44 Suppl 1():4-8. PubMed ID: 2691309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance therapies for reflux esophagitis.
    Yarze JC
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569839
    [No Abstract]   [Full Text] [Related]  

  • 40. Omeprazole in the short-term treatment of reflux oesophagitis.
    Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():40-6. PubMed ID: 2691310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.